Master pharmaceutical financial modeling and valuation techniques used by professional equity research analysts. Learn how to analyze pharma companies, forecast financial performance, build integrated financial models, and evaluate stock value using real-world valuation methods.

This course provides a practical, end-to-end approach to pharmaceutical equity research and financial modeling. You’ll explore the structure of the pharmaceutical industry, including APIs, generics, and regulatory factors, while learning how these drivers influence company performance and valuation outcomes. Through structured lessons and hands-on financial modeling workflows, you’ll build integrated income statement, balance sheet, and cash flow models using historical financial data. The course covers revenue forecasting, cost modeling, profitability analysis, working capital forecasting, depreciation modeling, and financial statement linkages to help learners construct accurate and dynamic financial models. A unique feature of this course is its strong industry-specific focus combined with practical valuation techniques used in equity research. You’ll learn how to calculate WACC, analyze free cash flow, and apply both Discounted Cash Flow (DCF) and relative valuation methods to derive data-driven investment recommendations. By the end of the course, you’ll be able to confidently build and validate pharmaceutical financial models, interpret key financial metrics, evaluate company valuation, and support professional investment analysis decisions.